THE 2ND INTERNATIONAL ANTICARDIOLIPIN STANDARDIZATION WORKSHOP THE KINGSTON ANTIPHOSPHOLIPID ANTIBODY STUDY (KAPS) GROUP

被引:450
作者
HARRIS, EN
机构
[1] Department of Medicine, Division of Rheumatology, University of Louisville, Louisville
关键词
Anticardiolipin; Antiphospholipid syndrome; ELISA standardization; Lupus anticoagulant; Systemic lupus erythematosus;
D O I
10.1093/ajcp/94.4.476
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Forty-three laboratories in 13 countries participated in a workshop to determine the degree of agreement between laboratories performing anticardiolipin tests. Each laboratory received freeze-dried aliquots of three samples labeled G1 (107 GPL units), G2 (20 GPL units), and G3 (6 GPL units) to be used as reference standards in the IgG assay, and three samples labeled M1 (106 MPL units), M2 (21 MPL units), and M3 (5 MPL units) as references for the IgM assay. Participating laboratories were divided into 8 groups and serum samples were exchanged between laboratories in each group. For IgG anticardiolipin, results were reported as: high, IgG positive for samples with optical absorbance readings exceeding G1; medium, IgG positive for samples with readings between G1 and G2; low, IgG positive between G2 and G3, and negative, if less than G3. In like manner, samples were defined as high-, medium-, or low-IgM positive, with reference to standards M1, M2, and M3. An index of agreement was computed to determine the degree of agreement between laboratories in each group. Interlaboratory agreement was excellent in each category assessed. For high positive and negative IgG and IgM results, the index of agreement exceeded 90%, and for medium and low positive results, agreement exceeded 75%. The overall index of agreement between laboratories exceeded 90%. The researchers conclude that the use of these six standards to obain a semiquantitative measure of anticardiolipin positivity will enable good interlaboratory agreement in reporting anticardiolipin results
引用
收藏
页码:476 / 484
页数:9
相关论文
共 26 条
  • [1] CORRELATION BETWEEN LUPUS ANTICOAGULANTS AND ANTICARDIOLIPIN ANTIBODIES IN PATIENTS WITH PROLONGED ACTIVATED PARTIAL THROMBOPLASTIN TIMES
    ALVING, BM
    BARR, CF
    TANG, DB
    [J]. AMERICAN JOURNAL OF MEDICINE, 1990, 88 (02) : 112 - 116
  • [2] A SOLID-PHASE ENZYME-IMMUNOASSAY (ELISA) FOR THE DETECTION AND QUANTITATION OF ANTICARDIOLIPIN ANTIBODY
    BISWAS, RM
    CRONIN, ME
    BOWERMAN, DL
    GRACY, DG
    MOORE, NA
    KLIPPEL, JH
    FLEISHER, TA
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1988, 90 (05) : 591 - 596
  • [3] BOWIE EJW, 1963, J LAB CLIN MED, V62, P416
  • [4] OBSTETRIC COMPLICATIONS ASSOCIATED WITH THE LUPUS ANTICOAGULANT
    BRANCH, DW
    SCOTT, JR
    KOCHENOUR, NK
    HERSHGOLD, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (21) : 1322 - 1326
  • [5] CARRERAS LO, 1982, THROMB HAEMOSTASIS, V48, P28
  • [6] CRONIN ME, 1988, J RHEUMATOL, V15, P795
  • [7] DISCORDANT EFFECTS OF PREDNISONE ON ANTICARDIOLIPIN ANTIBODIES AND THE LUPUS ANTICOAGULANT
    DERKSEN, RHWM
    BIESMA, D
    BOUMA, BN
    MEYLING, FHJG
    KATER, L
    [J]. ARTHRITIS AND RHEUMATISM, 1986, 29 (10): : 1295 - 1296
  • [8] COAGULATION SCREEN IS MORE SPECIFIC THAN THE ANTICARDIOLIPIN ANTIBODY ELISA IN DEFINING A THROMBOTIC SUBSET OF LUPUS PATIENTS
    DERKSEN, RHWM
    HASSELAAR, P
    BLOKZIJL, L
    MEYLING, FHJG
    DEGROOT, PG
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (05) : 364 - 371
  • [9] ANTICARDIOLIPIN ANTIBODIES - ISOTYPE DISTRIBUTION AND PHOSPHOLIPID SPECIFICITY
    GHARAVI, AE
    HARRIS, EN
    ASHERSON, RA
    HUGHES, GRV
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 1987, 46 (01) : 1 - 6
  • [10] HARRIS EN, 1987, CLIN EXP IMMUNOL, V68, P215